Jiangsu Bioperfectus Technologies Co Ltd (688399) — Working Capital to Net Assets Ratio
Jiangsu Bioperfectus Technologies Co Ltd (688399) has a Working Capital to Net Assets ratio of 42.1% as of September 2025. Working capital of CN¥1.25 Billion (current assets of CN¥1.79 Billion minus current liabilities of CN¥539.27 Million) is measured against net assets of CN¥2.97 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is Jiangsu Bioperfectus Technologies Co Ltd to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jiangsu Bioperfectus Technologies Co Ltd Working Capital to Net Assets (2016–2024)
This chart shows how Jiangsu Bioperfectus Technologies Co Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 42.1%, reflecting working capital of CN¥1.25 Billion against net assets of CN¥2.97 Billion CNY. See defensive interval ratio of Jiangsu Bioperfectus Technologies Co Ltd to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Jiangsu Bioperfectus Technologies Co Ltd (688399) total market value.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 54.5% | CN¥1.77 Billion | CN¥3.25 Billion | CN¥2.14 Billion | CN¥367.82 Million | ▼ -14.4 pp |
| 2023 | 68.9% | CN¥2.35 Billion | CN¥3.41 Billion | CN¥2.71 Billion | CN¥363.87 Million | ▼ -4.6 pp |
| 2022 | 73.5% | CN¥2.78 Billion | CN¥3.78 Billion | CN¥3.71 Billion | CN¥932.60 Million | ▲ +7.1 pp |
| 2021 | 66.4% | CN¥1.68 Billion | CN¥2.54 Billion | CN¥2.54 Billion | CN¥855.63 Million | ▼ -9.2 pp |
| 2020 | 75.5% | CN¥1.26 Billion | CN¥1.66 Billion | CN¥1.78 Billion | CN¥522.45 Million | ▼ -2.5 pp |
| 2019 | 78.0% | CN¥796.22 Million | CN¥1.02 Billion | CN¥890.45 Million | CN¥94.23 Million | ▲ +16.8 pp |
| 2018 | 61.2% | CN¥198.24 Million | CN¥324.10 Million | CN¥253.64 Million | CN¥55.40 Million | ▼ -16.7 pp |
| 2017 | 77.9% | CN¥202.68 Million | CN¥260.28 Million | CN¥250.80 Million | CN¥48.12 Million | ▼ -6.5 pp |
| 2016 | 84.4% | CN¥212.60 Million | CN¥251.90 Million | CN¥243.62 Million | CN¥31.02 Million | — |